Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tempest Therapeutics, Inc.

NASDAQ: TPST · Life Sciences · 12 alerts · CIK 1544227

Share price
$0.3418Close, Nov 16
Market cap
$6.83M
Shares outstanding
20MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tempest Therapeutics, Inc. filings on SEC EDGAR ↗

4:05 PM ET 8-K
Leadership Change

Tempest Therapeutics Leadership Change

Tempest Therapeutics announced the immediate resignation of Constance Ames as CFO for personal reasons. The company appointed Stephanie Horn-Warnock as the new Chief Financial Officer and Principal Financial and Accounting Officer, who will serve as a consultant at a rate of $450 per hour.

4:05 PM ET 8-K
Leadership Change

Tempest Therapeutics Leadership Change

Tempest Therapeutics appointed Mr. John Frederick as a Class III director to its Board of Directors, effective October 13, 2026. Mr. Frederick, a former CFO of Skillsoft Corp., will receive an initial option award to purchase 25,000 shares of common stock as part of his compensation under the company's non-employee director policy. The appointment is intended to strengthen the company's financial and capital markets expertise as it advances its in vivo CAR-T therapy pipeline.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.